WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

The Bright Future Amidst Challenges: An Outlook on China's Pharma Economy in 2... In an exclusive interview with Lin Jianning by SMEI's Menet, a seasoned pharmaceutical economic research expert and former party secretary of the SMEI, the future trends ...
(3/10/2025)

China Biopharma Tracker – February 2025 (Phar... (3/10/2025)

The Bright Future Amidst Challenges: An Outloo... (3/10/2025)

AI, Biomanufacturing, and Six Takeaways from C... (3/6/2025)

Trump's 'America First' Investment Policy Rais... (3/4/2025)

Pace, Price of China Licensing Deals Continues... (2/28/2025)

China's Tech Giants Look to Healthcare (The Wi... (2/28/2025)

Fail to Launch: Affordable Gene Therapy from C... (2/27/2025)

Chinese Biotech Firms Cash in on Promising Dru... (2/26/2025)

Lessons from China's 2024 National Negotiation... (2/21/2025)

It's Not Just AI. China's Medicines Are Surpri... (2/19/2025)

China Performance of Leading MNCs Fell in H2/2... (2/18/2025)

Cash-Strapped Chinese Biotechs A Growing Draw ... (2/18/2025)

Insilico Medicine Secures $110M, Explore... (3/13/2025) China Issues Guidelines for Informatizat... (3/13/2025) AskBio Receives FDA Regenerative Medicin... (3/13/2025) NewDEL Biotech Completes Series A+ Finan... (3/12/2025) Novartis' Cosentyx Receives Fifth Indica... (3/12/2025) Harbour BioMed Launches Élancé Therape... (3/12/2025) CDE Publicizes the List of Reference For... (3/12/2025) Pfizer's PD-L1 Targeting ADC Receives Cl... (3/12/2025) Eli Lilly Plans Late 2025 Launch of Weig... (3/12/2025) CSPC Advances Phase II Trial of Nectin-4... (3/12/2025) Akeso Initiates Phase III Trial of Ivone... (3/12/2025) Over 100 Chinese Pharma Firms Report Los... (3/11/2025) Chinese Scientists Develop Potential Vac... (3/11/2025) MindRank's AI-Designed Dual Kinase Inhib... (3/11/2025) Pfizer's Elrexfio Receives Conditional A... (3/11/2025) Juvensis Secures Over CNY 100M in Pre-A... (3/11/2025) RockRoc Secures Pre-A+ Financing to Adva... (3/11/2025) InnoCare Presents Promising Phase II Dat... (3/11/2025)

China's Retail Pharmacy Market Reaches CNY 574 Billion ... China's Pharmaceutical Market Shrinks in 2024 Amid Stru... NH Reports Latest Data on Chinese Smoking Control Marke... NH Reports on Booming Chinese Sedatives and Sleep Aids ... NH Reports Latest Data on the Chinese Eye Care Market i...

Insilico Medicine Secures $110M, Explores IPO Amid AI D... Eli Lilly Plans Late 2025 Launch of Weight Loss Drugs i... Harbour BioMed Launches Élancé Therapeutics to Advanc... NewDEL Biotech Completes Series A+ Financing Led by Xta... Juvensis Secures Over CNY 100M in Pre-A Financing to A...

CDE Publicizes the List of Reference Formulations for G... CDE Seeks Public Feedback on "SPARK Initiative" to Boos... NMPA Announces Package Insert Revision of Fluorouracil ... China Holds 2025 National Drug Regulation Conference, S... CDE Issues on the Guidelines for Clinical Trial Design ...

China Issues Guidelines for Informatization of County-L... China to Expand Mental Health Services Nationwide: Offi... China's Life Expectancy Reaches 79 Years in 2024, Surpa... China Expands BMI Coverage to Over 90% of Village Clini... China to Adjust Centralized Drug Procurement Policies

Novo Nordisk Sues KBP Biosciences for $830 Million Over... State Council Releases Final Antitrust Guidelines for t... Bayer Initiates Patent Infringement Lawsuit Against Hen... Oxford Nanopore Sues Chinese Biotech Giant BGI Over All... Congress Debates Biosecure Act Amid Report Highlighting...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

AskBio Receives FDA Regenerative Medicine Advanced Ther... Akeso Initiates Phase III Trial of Ivonescimab Plus Che... CSPC Advances Phase II Trial of Nectin-4 ADC SYS6002 fo... Pfizer's PD-L1 Targeting ADC Receives Clinical Trial Ap... Novartis' Cosentyx Receives Fifth Indication Approval i...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Former NMPA Deputy Commissioner Under Investigation Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...